The development of megakaryocytes (MKs) from their marrow precursors is one of the least understood aspects of hematopoiesis. Current models suggest that earlyacting MK colony-stimulating factors, such as interleukin (IL) 3 or c-kit ligand, are required for expansion of hematopoietic progenitors into cells capable of responding to lateacting MK potentiators, including IL-6 and IL-li. Recently, the Mpl ligand, or thrombopoietin (Tpo), has been shown to display both MK colony-stimulating factor and potentiator activities, at potencies far greater than that of other cytokines. In light of these findings, we tested the hypothesis that Tpo is absolutely necessary for MK development. In this report we demonstrate that neutralizing the biological activity of Tpo eliminates MK formation in response to c-kit ligand, IL-6, and IL-11, alone and in combination, but that these reagents only partially reduce MK formation in the presence of combinations of cytokines including IL-3. However, despite the capacity of IL-3 to support the proliferation and initial stages of MK differentiation, elimination of Tpo prevents the full maturation of IL-3-induced MK. These data indicate that two populations of MK progenitors can be identified: one that is responsive to IL-3 but can fully develop only in the presence of Tpo and a second that is dependent on Tpo for both proliferation and differentiation. Thus, our results strongly suggest that Tpo is the primary regulator of MK development and platelet production.
The generation of megakaryocytes (MKs) is a complex process dependent on the interaction of hematopoietic progenitor cells, cytokines, and stromal elements (1) (2) (3) . Committed MK progenitor cells must undergo a series of mitotic divisions, shift to endomitotic replication, express specific membrane glycoproteins, and undergo cytoplasmic maturation in preparation for platelet shedding. Models of erythropoiesis and granulopoiesis have been established that stress the importance of both early-acting and late-acting cytokines or hormones for completion of the erythroid and granulocytic developmental programs (4) (5) (6) . A number of investigators have shown that interleukin (IL) 3 and c-kit ligand (KL) can support the production of MK colonies from their progenitors [MK colony-forming units (CFU-MK)] in semisolid medium and of individual MKs in suspension culture (7) (8) (9) (10) . Moreover, although IL-6, IL-11, and leukemia inhibitory factor are not reported to support MK formation alone, these cytokines augment the MK response to IL-3 or KL (11) (12) (13) (14) . Recently, we (15) and other groups (16, 17) have cloned and expressed the ligand for the c-Mpl receptor. Based on its capacity to induce increases in the size, ploidy, and maturation of MKs, its inverse relationship with platelet levels, and its ability to increase platelet production manyfold (18, 19) , we proposed that the Mpl ligand is identical to thrombopoietin (Tpo) (20, 21) .
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Like IL-3 and KL, Tpo can support the growth of MKs in both semisolid and suspension culture systems. However, interpretation of results using either of these techniques has limitations: agar cultures usually contain serum, which could introduce known or unknown growth factors, and suspension cultures usually contain unfractionated marrow cells at high density, which could facilitate endogenous production of cytokines or direct cellular interactions. To determine whether IL-3, KL, or Tpo acts directly to induce MK differentiation, we tested these cytokines, alone and in combination with IL-6 and IL-11, for their capacity to promote MK growth in the presence of reagents that neutralize Tpo activity. In the present work we provide evidence for the existence of two populations of MK progenitor cells: the first absolutely dependent on the presence of Tpo and the second able to initially develop in response to IL-3 but requiring Tpo for full maturation. Thus, our results strongly suggest that full MK development and platelet production is dependent on the presence of Tpo.
MATERIALS AND METHODS
Reagents. Murine Tpo was produced in BHK cells under serum-free conditions as described (15) . By definition, 50 units is that amount which supports half-maximal proliferation in a BaF3/mpl MTT assay. Soluble murine c-Mpl containing a 5-residue cAMP-dependent kinase domain (RRASV; ref. 22) and a six-residue polyhistidine tail at the carboxyl terminus of the extracytoplasmic domain was prepared by site-directed mutagenesis. The cDNA was expressed in BHK cells, purified by metal chelation affinity chromatography, and eluted with imidazole buffer (23) . For use in culture, purified soluble receptor was twice dialyzed against pyrogen-free phosphatebuffered saline and filter-sterilized. Protein concentrations were estimated by comparing intensity of Coomassie blue staining with albumin controls. Murine (m) IL-3, mKL, human IL-6, and human IL-11 were purchased from Genzyme. Nutridoma-SP culture supplement was purchased from Boehringer Mannheim and horse serum was from GIBCO/BRL. The neutralizing anti-mIL-3 monoclonal antibody (mAb) 19B3, provided by John Abrams (DNAX), was used at 5 ,ug/ml and completely eliminated MK formation in suspension culture and BaF3/mpl cell proliferation in response to IL-3 at 20 ng/ml (15) . The neutralizing anti-murine c-kit mAb ACK-2, provided by Shin-Ichi Nishikawa, was used as hybridoma supernatant at 5% (vol/vol) and completely eliminated acetylcholinesterase (AChE) activity in suspension cultures in the presence of KL at 20 ng/ml (14) . The neutralizing rabbit anti-murine c-Mpl antiserum (raised against soluble Mpl receptor by Zymogenetics) was purified by protein A-Sepharose chromatography (Pharmacia) and used at 5 ,g/ml. At this Abbreviations: MK, megakaryocyte; IL, interleukin; KL, c-kit ligand; CSF, colony-stimulating factor; Tpo, thrombopoietin; CFU, colonyforming unit(s); mAb, monoclonal antibody; AChE, acetylcholinesterase; m, murine; GM, granulocyte-macrophage; E, erythroid. tTo whom reprint requests should be addressed. (11) . All cultures were incubated for 5 days at 37°C in a 5% C02/95% air fully humidified atmosphere. MK mass was evaluated by determining AChE activity levels in a fluorescence assay (11) . MK size was measured by calibrated microscopy after AChE staining, and ploidy was determined as reported (18) . Cultures for erythroid [erythroid CFU (CFU-E)] and myeloid [granulocyte-macrophage CFU (CFU-GM)] progenitor cell-derived colonies were grown in plasma clot and methylcellulose assays, respectively, as described (24, 25) .
Detection ofTpo. The biological activity of Tpo was detected by using a specific BaF3/mpl proliferation assay (15) in which any mIL-3 present was neutralized using mAb 19B3. These cells fail to respond to IL-5, IL-6, IL-11, KL, granulocytemacrophage colony-stimulating factor (GM-CSF), or erythropoietin. To detect Tpo-specific mRNA, marrow cells similar to those used to initiate cultures were lysed and RNA was prepared. First-strand cDNA was prepared using Superscript reverse transcriptase (GIBCO/BRL) and 30 cycles of PCR was carried out with sense and antisense primers located 412 and 1087 nt from the initiation codon (15) . Glyceraldehyde 3-phosphate dehydrogenase primers were included as a measure of cDNA integrity. PCR products were size-fractionated on 0.8% agarose gels and visualized with ethidium bromide staining.
RESULTS
Soluble Murine c-Mpl Neutralizes the Biological Activity of Tpo. Dose-response curves using Tpo and soluble receptor (1.5 ,ug/ml) were constructed by using murine marrow MK colony-forming assays. As shown in Fig. 1 , concentrations of Tpo at or below 100 units/ml were completely neutralized by soluble c-Mpl at 1.5 ,ug/ml, higher concentrations of Tpo (3000 units/ml) were able to overcome some of this effect. However, to be certain that the results using the soluble receptor were specific to megakaryopoiesis and not due to nonspecific toxicity, we tested for effects on CFU-E-and CFU-GM-derived colony formation and on IL-3-induced proliferation of BaF3 cells. There were no significant differences in the number of either erythroid colonies (CFU-E = 199 + 2 vs. 191 ± 9.5 in response to 0.1-0.5 unit of erythopoietin, n = 2) or myeloid colonies (CFU-GM = 113 + 4.3 vs. 115 ± 4.7 in response to IL-3 at 20 ng/ml, n = 3) formed in absence or presence of soluble c-Mpl at 1.5 ,ug/ml, respectively. BaF3 cells grown in IL-3 at 30 units/ml were unaffected by the soluble receptor.
Soluble c-Mpl Inhibits MK Formation in Response to IL-3, KL, IL-6, and IL-li. Numerous groups (7) (8) (9) (10) (11) (12) (13) (14) have described the effects of cytokines on MK colony growth, most notably for IL-3, KL, IL-6, and IL-11, alone and in combination. However, all of the reported results utilize culture systems containing a large number of potential accessory cells and/or serum that might produce or contain Tpo. To test which cytokines are ultimately responsible for megakaryopoiesis, murine marrow cells were cultured with MK-promoting proteins in the presence and absence of soluble c-Mpl. In the presence of soluble receptor, KL-, IL-6-, and IL-11-induced colony formation was essentially eliminated, and IL-3-induced colonies were reduced to 39% of control cultures ( Fig. 2A) . MK 
To be certain that the results using Mpl-neutralizing reagents were not due to serum present in the agar cultures, we used a serum-free suspension culture system (14 (12, 14) . However, in combination with IL-3 or KL, both IL-6 and IL-11 induced supraadditive levels of AChE activity above that seen in control cultures (Fig. 2B) Fig. 3 , Tpo-specific mRNA was readily detected. However, the origin of the specific mRNA (nonhematopoietic cells or the MKs themselves) could not be discerned with our present methods. (Fig. 4A) . In contrast, MKs obtained from cultures containing Tpo exhibited abundant development of demarcation membranes primarily in the peripheral zone. However, the number and distribution of cytoplasmic organelles were aberrant in showing an excessive number of mitochondria and autophagic vacuoles (Fig. 4B ). In the presence of IL-3 and Tpo, the formation of demarcation membranes was exuberant, and the range in size of cytoplasmic fragments resembled that seen during normal in vivo thrombocytopoiesis (Fig. 4C) . Thus, IL-3 can support the proliferation and initial stages of MK development; full differentiation, however, to the level of thrombocytopoiesis is dependent on Tpo.
DISCUSSION
Over the past decade a number of distinct cytokines have been shown to influence MK development in various in vitro assays, by using marrow cells from both animals and humans. The cytokines that affect megakaryopoiesis have been divided into two groups: MK-CSFs, which affect the proliferation of MK progenitors and include IL-3 (4, 5), KL (9, 10), and GM-CSF (26) , and MK potentiators, cytokines that affect the immediate precursors of polyploid MKs including IL-6 (11, 12), IL-11 (13, 14) , and leukemia inhibitory factor (14) . The recent cloning and biological characterization of the Mpl ligand have provided insights into the biology of MK development. By using recombinant or purified protein, we (18) and others (16, 17, 19) have shown that the Mpl ligand supports both functions; Mpl ligand, alone and in combination with other cytokines, stimulates the production of MK colonies and acts late in MK development to increase MK size, polyploidization, and the expression of platelet-specific cell surface glycoproteins. On the basis of its wide-ranging activities restricted to megakaryo- poiesis, we proposed that the Mpl ligand be termed thrombopoietin (Tpo) (15, 18) .
Given the potency and range of activities of Tpo on megakaryopoiesis, we investigated the possibility that the effects of IL-3, KL, IL-6, and IL-11 were mediated through Tpo. To test this hypothesis, we used reagents that neutralized the biological activities of IL-3, KL, or Tpo, in cultures that support MK development. Our results strongly support this hypothesis. Neutralization of Tpo activity led to the elimination of MK formation in response to KL, IL-6, or IL-11, alone and in combination, to levels below that found in control cultures. In contrast, neutralization of KL had no effect on Tpo-induced megakaryopoiesis.
The effects of neutralizing Tpo in cultures containing cytokine combinations including IL-3 were more complex. At 20 ng/ml, IL-3-induced MK formation, alone or in combination with low concentrations of IL-6 (5 ng/ml) or IL-11 (5 ng/ml), was eliminated by soluble Mpl receptor (data not shown). However, the presence of 10-fold higher concentrations of IL-3, especially in combination with IL-6 at 50 ng/ml or IL-11 at 50 ng/ml, could partially overcome this effect. These results suggest that IL-3 acts through both Tpo-dependent and Tpoindependent mechanisms. But despite the capacity of the cytokine to support the initial stages of development, IL-3-induced MKs fail to fully mature. This conclusion is based on the size, ploidy, and electron microscopic morphology of IL-3-induced MKs. Thus, IL-3-induced MK progenitors likely require Tpo for the formation and release of platelets.
The hypothesis that megakaryopoiesis is regulated at multiple levels was advanced by Williams et al (27) and others (36, 37) . On the basis of existing data relating to the effects of IL-3 on single MKs and their progenitors, these investigators proposed that both IL-3-dependent and IL-3-independent (Tpo) pathways could give rise to marrow MKs. Although our data conflict with some of the details of these earlier models (e.g., it is clear that Tpo influences not only the differentiation of MKs but also the proliferation of MK progenitor cells), our results are consistent with the basic principles of a dual system of megakaryopoietic regulation, mediated by two populations of progenitors and two distinct cytokines. However, because of the complex cellular nature of our culture systems, absolute verification of this hypothesis awaits the development of a single-cell serum-free culture system for purified MK progenitors.
Results from recent gene knock-out studies are also consistent with a dual system of MK development. By using homologous recombination at the murine c-mpl locus to eliminate receptor expression, Gurney et at (28) have shown that MK numbers and platelet counts are substantially reduced but not eliminated. Unfortunately, characteristics of the residual MKs and platelets were not provided in this report. These workers hypothesized that another cytokine system is responsible for the residual thrombopoiesis or that elevated Tpo levels in the -/-mice operate through an alternate receptor. Our results cannot distinguish between these possibilities. Although MKs fail to fully mature in the absence of Tpo, IL-3-induced MKs may be able to sustain residual platelet production in vivo. However, such pathways to platelet production are very unlikely to provide the rapid and profound expansion of platelet production in states of increased need.
The crossing of Mpl -/-and IL-3 -/-strains may thus provide important insights into thrombopoiesis.
The simplest explanation for our results is that accessory cells in our culture systems produce the Tpo necessary for MK formation. The absence of Tpo activity in a biological assay suggests that Tpo produced in these culture systems might be rapidly consumed or be present at levels too low to detect. A similar conclusion was drawn regarding the production of other CSFs in long-term bone marrow cultures (LTBMCs). Numerous biological assays failed to detect macrophage-, granulocyte-, or GM-CSF in the spent medium from such cultures (29) . The apparent absence of specific protein was initially taken as evidence that CSFs are not produced in LTBMCs. Only after the withdrawal of proliferating hematopoietic cells (which actively consume CSFs) or the use of sensitive immunological assays was CSF protein detectable (30, 31) . Despite our inability to detect Tpo by bioassay, our results using reverse transcription-PCR demonstrating the presence of Tpo-specific mRNA in marrow strongly support our contention that Tpo is produced in vitro and that development of the majority of MKs is directly attributable to its presence.
Our conclusions about the dependence of megakaryopoiesis on Tpo are quite similar to results from studies of erythropoiesis. A number of cytokines enhance the growth and development of early erythroid progenitors (erythroid blastforming units). The cytokines that display such burstpromoting activity are remarkably similar to those that support early MK colony formation and include IL-3, KL, and GM-CSF (26, (32) (33) (34) . And like the role of Tpo in MK development, the presence of erythropoietin is absolutely essential for the production of mature erythrocytes (for review, see ref. 35 ). Thus, it would appear that cytokine control of megakaryopoiesis is organized much like that of erythropoiesis.
Finally, in addition to providing a better understanding of MK physiology, our results have important implications for the clinical application of cytokines in states of decreased platelet production. As the development and maturation of MKs appears to be absolutely dependent on the presence of Tpo, it is very likely that this molecule, rather than other cytokines that act indirectly or in synergy with it, will have the most profound effect on platelet production in clinical settings of natural or therapy-induced thrombocytopenia.
